Showing results (301-310 of 1,757) with videos related to
Sort By:
Pageof 176
Vascular Pharmacology|May 29, 2016
Vascular disrupting activity of combretastatin analoguesElena Porcù, Alessia Salvador, Irina Primac, et al.Vascular Pharmacology|May 8, 2016
A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcificationDongxing Zhu, Nabil A Rashdan, Karen E Chapman, et al.Vascular Pharmacology|June 4, 2016
Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosisNatalia Di Pietro, Gloria Formoso, Assunta PandolfiVascular Pharmacology|November 18, 2017
Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesisXiyu Mei, Lingyu Zhou, Tianyu Zhang, et al.Vascular Pharmacology|December 6, 2017
Effects of endurance training on serum lipidsKati Fikenzer, Sven Fikenzer, Ulrich Laufs, et al.Vascular Pharmacology|November 28, 2017
The minor histocompatibility antigen 1 (HMHA1)/ArhGAP45 is a RacGAP and a novel regulator of endothelial integrityJ Amado-Azevedo, N R Reinhard, J van Bezu, et al.Vascular Pharmacology|December 17, 2017
Periadventitial local drug delivery to target restenosisBelay TesfamariamVascular Pharmacology|October 24, 2017
Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseasesAnja Hofmann, Coy Brunssen, Henning MorawietzVascular Pharmacology|July 9, 2016
Low-level lead exposure changes endothelial modulation in rat resistance pulmonary arteriesEmilia Polaco Covre, David Domingues Freire, Bruna Miurim Dalfior, et al.Vascular Pharmacology|November 25, 2020
Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1/PPAR-γaxisShuhao Zhang, Jiantao Liu, Kaidi Zheng, et al.Pageof 176